Affiliation:
1. The First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China
2. Henan University of Chinese Medicine, Zhengzhou, Henan, China
Abstract
Shenfuyixin granule (SFYXG, i.e., Xinshuaikang granule) is a prescription, commonly used in the clinical experience, which plays a significant role in the treatment of heart failure. The purpose of this present research was to investigate the protective effect of SFYXG, and the mechanism about anti-H2O2-induced oxidative stress and apoptosis in the neonatal rat cardiomyocytes. Myocardial cells, as is well known, were divided into 4 groups: normal, model, SFYXG, and coenzyme Q10 group, respectively. Cells viability was determined by MTT assay. Flow cytometry and AO/EB staining were implemented to test the apoptosis rate and intracellular reactive oxygen species (ROS) level. Mitochondrion membrane potential (MMP) was evaluated by JC-1 fluorescence probe method. The myocardial ultrastructure of mitochondrion was measured by electron microscope. The related mRNA expression levels of Bax, Bcl-2, Caspase-3, caspase-8, and caspase-9 were detected by real-time polymerase chain reaction (PCR). Also, the expression levels of Bax and Bcl-2 protein were detected by Western blot, and the expression levels of caspase-3, caspase-8, and caspase-9 protein were tested by caspase-Glo®3 Assay, caspase-Glo®8 Assay, and caspase-Glo®9 Assay, respectively. GAPDH was used as the internal reference gene/protein. The results revealed that SFYXG (0.5 mg/ml) raised the viability of myocardial cell, weakened the apoptosis rate and ROS level, corrected the mitochondrion membrane potential stability, and improved cell morphology and ultrastructure of myocardial mitochondrion. Furthermore, SFYXG upregulated the antiapoptosis gene of Bcl-2, but downregulated the proapoptosis genes of Bax, caspase-3, and caspase-9. In conclusion, SFYXG could appear to attenuate myocardial injury by its antioxidative and antiapoptosis effect.
Funder
National Natural Science Foundation of China
Subject
Complementary and alternative medicine
Reference23 articles.
1. ROS and RNS signaling in heart disorders: could antioxidant treatment be successful;I. Afanas’ev;Oxidative Medicine and Cellular Longevity,2011
2. Voors1 Treating oxidative stress in heart failure:past, present and future;A. van der Pol;European Journal of Heart Failure,2019
3. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species- mediated apoptotic and autophagic pathways;T. Fan;European Journal of Pharmacology,2018
4. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants;B. Poljsak;Oxidative Medicine and Cellular Longevity,2013
5. Antioxidants in cardiovascular therapy: panacea or false hope;K. Goszcz;Frontiers in Cardiovascular Medicine,2015